Skip to main content
logo
Nxera Pharma Co., Ltd. (TYO:4565)
Japan flag Japan · Delayed Price · Currency is JPY
905.00
+54.00 (6.35%)
At close: Mar 6, 2026

Nxera Pharma Revenue

In the year 2025, Nxera Pharma had annual revenue of 29.62B JPY with 2.71% growth. Nxera Pharma had revenue of 7.77B in the quarter ending December 31, 2025, with 13.35% growth.

Revenue
29.62B
Revenue Growth
+2.71%
P/S Ratio
2.77
Revenue / Employee
77.53M
Employees
382
Market Cap
81.90B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.62B780.00M2.71%
Dec 31, 202428.84B16.07B125.87%
Dec 31, 202312.77B-2.80B-18.00%
Dec 31, 202215.57B-2.14B-12.10%
Dec 31, 202117.71B8.87B100.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Takara Bio44.15B
GNI Group26.84B
PeptiDream18.52B
RaQualia Pharma3.98B
Japan Tissue Engineering2.26B
AnGes874.00M
Cuorips356.00M
Renascience107.00M
Revenue Rankings

Nxera Pharma News

More News